These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 10616201)

  • 1. Angiotensin-converting enzyme inhibition prevents loss of glomerular hydraulic permeability in passive heymann nephritis.
    Remuzzi A; Monaci N; Bonassi ME; Corna D; Zoja C; Mohammed EI; Remuzzi G
    Lab Invest; 1999 Dec; 79(12):1501-10. PubMed ID: 10616201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
    Zoja C; Corna D; Bruzzi I; Foglieni C; Bertani T; Remuzzi G; Benigni A
    Exp Nephrol; 1996; 4(4):213-21. PubMed ID: 8983642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade on the evolution of spontaneous glomerular injury in male MWF/Ztm rats.
    Remuzzi A; Malanchini B; Battaglia C; Bertani T; Remuzzi G
    Exp Nephrol; 1996; 4(1):19-25. PubMed ID: 8788596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement-independent nephrotoxic serum nephritis in Munich Wistar rats. Immunologic and ultrastructural studies.
    Pilia PA; Boackle RJ; Swain RP; Ainsworth SK
    Lab Invest; 1983 May; 48(5):585-97. PubMed ID: 6341711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence of events in the glomerular capillary wall at the onset of proteinuria in passive Heymann nephritis.
    Fujigaki Y; Batsford S; Yamashita F; Yonemura K; Hishida A; Kawachi H; Shimizu F; Vogt A
    Virchows Arch; 2001 Feb; 438(2):136-45. PubMed ID: 11253115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental glomerulonephritis in the guinea pig. II. Ultrastructural lesions of the basement membrane associated with proteinuria.
    Couser WG; Spargo BH; Stilmant MM; Lewis EJ
    Lab Invest; 1975 Jan; 32(1):46-55. PubMed ID: 1089838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmented expression of glomerular basement membrane specific type IV collagen isoforms (alpha3-alpha5) in experimental membranous nephropathy.
    Minto AW; Kalluri R; Togawa M; Bergijk EC; Killen PD; Salant DJ
    Proc Assoc Am Physicians; 1998; 110(3):207-17. PubMed ID: 9625527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrastructural change of the glomerular basement membrane in rats with Heymann nephritis revealed by ultrahigh resolution scanning electron microscopy.
    Hironaka K; Makino H; Onbe T; Yamasaki Y; Shikata K; Kamata K; Ota Z
    J Pathol; 1996 May; 179(1):112-20. PubMed ID: 8691335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cyclooxygenases reduces complement-induced glomerular epithelial cell injury and proteinuria in passive Heymann nephritis.
    Takano T; Cybulsky AV; Cupples WA; Ajikobi DO; Papillon J; Aoudjit L
    J Pharmacol Exp Ther; 2003 Apr; 305(1):240-9. PubMed ID: 12649375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe glomerular epithelial cell damage does not prevent passive Heyman nephritis in rats.
    Bertani T; Remuzzi G; Poggi A; Delaini F; Sacchi G; Morassi L; Verroust P; Mecca G; Donati MB
    Clin Exp Immunol; 1983 Jan; 51(1):38-44. PubMed ID: 6339125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long-term evolution of immune deposits in passive Heymann nephritis.
    Soares VA; Almeida DB
    Braz J Med Biol Res; 1992; 25(2):149-59. PubMed ID: 1339511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease.
    Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD
    J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of glomerular lesions involves coordinated restructuring of glomerular microvasculature.
    Adamczak M; Gross ML; Amann K; Ritz E
    J Am Soc Nephrol; 2004 Dec; 15(12):3063-72. PubMed ID: 15579509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of passive Heymann glomerulonephritis: chlorpromazine inhibits antibody-mediated redistribution of cell surface antigens and prevents development of the disease.
    Camussi G; Noble B; Van Liew J; Brentjens JR; Andres G
    J Immunol; 1986 Mar; 136(6):2127-35. PubMed ID: 3485141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of angiotensin-converting enzyme inhibition on glomerular basement membrane permeability and distribution of zonula occludens-1 in MWF rats.
    Macconi D; Ghilardi M; Bonassi ME; Mohamed EI; Abbate M; Colombi F; Remuzzi G; Remuzzi A
    J Am Soc Nephrol; 2000 Mar; 11(3):477-489. PubMed ID: 10703671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine lupus nephritis. A structure-function study.
    Kiberd BA
    Lab Invest; 1991 Jul; 65(1):51-60. PubMed ID: 2072665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of alterations in glomerular charge on deposition of cationic and anionic antibodies to fixed glomerular antigens in the rat.
    Adler S; Baker P; Pritzl P; Couser WG
    J Lab Clin Med; 1985 Jul; 106(1):1-11. PubMed ID: 3891891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis.
    Makker SP; Tramontano A
    J Pathol; 2006 Nov; 210(3):282-7. PubMed ID: 16981232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist.
    Zoja C; Donadelli R; Corna D; Testa D; Facchinetti D; Maffi R; Luzzana E; Colosio V; Bertani T; Remuzzi G
    Am J Kidney Dis; 1997 Feb; 29(2):254-64. PubMed ID: 9016898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A change in glomerular permeability in renovascular hypertension. Participation of angiotensin and structural lesions].
    Franco M; Tapia E; Gabbai F; Cermeño JL; Calleja C; Pérez JM; Barrios R; Torres G; González FJ; Alvarado JA
    Arch Inst Cardiol Mex; 1986; 56(1):13-24. PubMed ID: 2943240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.